Genic Financials
| 123330 Stock | KRW 23,300 1,050 4.72% |
Genic |
Understanding current and past Genic Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genic's financial statements are interrelated, with each one affecting the others. For example, an increase in Genic's assets may result in an increase in income on the income statement.
Please note, the presentation of Genic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Genic's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Genic's management manipulating its earnings.
Genic Stock Summary
Genic competes with Busan Industrial, Finebesteel, Shinhan Inverse, Fine Besteel, and Hyundai Heavy. Genic Co., Ltd. researches, develops, manufactures, and sells hydrogel mask packs in South Korea and internationally. The company was founded in 2001 and is based in Seongnam-si, South Korea. Genic is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7123330003 |
| Business Address | Solbrain Building, Seongnam-si, |
| Sector | Personal Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.genic21.com |
| Phone | 82 3 1725 5600 |
| Currency | KRW - South Korean Won |
You should never invest in Genic without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Genic Stock, because this is throwing your money away. Analyzing the key information contained in Genic's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Genic Key Financial Ratios
Genic's financial ratios allow both analysts and investors to convert raw data from Genic's financial statements into concise, actionable information that can be used to evaluate the performance of Genic over time and compare it to other companies across industries.| Return On Equity | -18.36 | |||
| Return On Asset | -0.02 | |||
| Target Price | 31397.0 | |||
| Number Of Employees | 204 | |||
| Beta | 1.39 |
Genic Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genic's current stock value. Our valuation model uses many indicators to compare Genic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genic competition to find correlations between indicators driving Genic's intrinsic value. More Info.Genic Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Genic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genic's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Genic Systematic Risk
Genic's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Genic volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Genic correlated with the market. If Beta is less than 0 Genic generally moves in the opposite direction as compared to the market. If Genic Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Genic is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Genic is generally in the same direction as the market. If Beta > 1 Genic moves generally in the same direction as, but more than the movement of the benchmark.
Genic January 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Genic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genic Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genic Co based on widely used predictive technical indicators. In general, we focus on analyzing Genic Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genic's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.7 | |||
| Information Ratio | 0.0194 | |||
| Maximum Drawdown | 22.84 | |||
| Value At Risk | (7.72) | |||
| Potential Upside | 11.69 |
Complementary Tools for Genic Stock analysis
When running Genic's price analysis, check to measure Genic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genic is operating at the current time. Most of Genic's value examination focuses on studying past and present price action to predict the probability of Genic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genic's price. Additionally, you may evaluate how the addition of Genic to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |